Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000919574-26-003800
Filing Date
2026-06-03
Accepted
2026-06-03 16:10:26
Documents
1
Period of Report
2026-06-01

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4858
  Complete submission text file 0000919574-26-003800.txt   6566
Mailing Address C/O BEONE MEDICINES I GMBH AESCHENGRABEN 27, 21ST FLOOR BASEL Switzerland 4051
Business Address C/O BEONE MEDICINES I GMBH AESCHENGRABEN 27, 21ST FLOOR BASEL Switzerland 4051 41-616851900
BeOne Medicines Ltd. (Issuer) CIK: 0001651308 (see all company filings)

EIN.: 981209416 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O MOURANT OZANNES CORPORATE SERVICES 94 SOLARIS AVENUE CAMANA BAY, GRAND CAYMAN Cayman Islands KY1-1108
Business Address
Yi Qingqing (Reporting) CIK: 0001662556 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37686 | Film No.: 261060708